Cindy Davis

Pretoria, GT, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Evaluation of the biodistribution of [99mTc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [68Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy.

Evaluation of the biodistribution of [99mTc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [68Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy.

Journal: EJNMMI research

Published: March 25, 2026

Clinical Image-Based Dosimetry of Actinium-225 in Targeted Alpha Therapy.

Clinical Image-Based Dosimetry of Actinium-225 in Targeted Alpha Therapy.

Journal: Cancers

Published: December 11, 2025

Multidisciplinary Approach to Theranostics Around the World: Integration of Care Teams.

Multidisciplinary Approach to Theranostics Around the World: Integration of Care Teams.

Journal: Journal of nuclear medicine technology

Published: September 04, 2025

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study.

Journal: The Lancet. Oncology

Published: October 26, 2023

Correlation between [68Ga]Ga-FAPI-46 PET Imaging and HIF-1α Immunohistochemical Analysis in Cervical Cancer: Proof-of-Concept.

Correlation between [68Ga]Ga-FAPI-46 PET Imaging and HIF-1α Immunohistochemical Analysis in Cervical Cancer: Proof-of-Concept.

Journal: Cancers

Published: June 02, 2023

[68Ga]Ga-NODAGAZOL uptake in atherosclerotic plaques correlates with the cardiovascular risk profile of patients.

[68Ga]Ga-NODAGAZOL uptake in atherosclerotic plaques correlates with the cardiovascular risk profile of patients.

Journal: Annals of nuclear medicine

Published: January 26, 2022

A Prospective Investigation of Tumor Hypoxia Imaging with 68Ga-Nitroimidazole PET/CT in Patients with Carcinoma of the Cervix Uteri and Comparison with 18F-FDG PET/CT: Correlation with Immunohistochemistry.

A Prospective Investigation of Tumor Hypoxia Imaging with 68Ga-Nitroimidazole PET/CT in Patients with Carcinoma of the Cervix Uteri and Comparison with 18F-FDG PET/CT: Correlation with Immunohistochemistry.

Journal: Journal of clinical medicine

Published: December 19, 2021

mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post-Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis.

mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post-Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 30, 2021

[68Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with 18F[FDG] PET Imaging.

[68Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with 18F[FDG] PET Imaging.

Journal: Biomolecules

Published: November 14, 2020

Correction to: 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.

Correction to: 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 27, 2019

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy.

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 28, 2019

225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.

225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 19, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026